CAR-T Therapy to Join Rajasthan Government Health Scheme
The Rajasthan government announced in August 2026 that CAR-T cell therapy would be included in the Rajasthan Government Health Scheme (RGHS) packages for eligible state government employees and their dependants. Chief Minister Bhajanlal Sharma shared the decision on X.
Coverage and Treatment Conditions
The measure is intended to extend access to CAR-T cell therapy for eligible patients with serious blood cancers. The scheme is reported to cover costs of up to ₹30 lakh, including manufacturing, hospitalisation and toxicity management. Beneficiaries must follow applicable RGHS provisions and the Rajasthan government’s oncology guidelines issued on June 6, 2026. Facilities for the therapy are available at Sawai Man Singh Hospital in Jaipur.
Important Facts for Exams
- Receptor design: A chimeric antigen receptor combines antigen recognition and T-cell activation in one engineered receptor protein.
- Four-part structure: CARs comprise an antigen-recognition domain, extracellular hinge, transmembrane domain and intracellular T-cell signalling domain.
Category: Rajasthan
Originally written on
August 19, 2026
and last modified on
November 20, 2026.
Tags: Bhajanlal Sharma, CAR-T cell therapy, oncology guidelines, Rajasthan, Rajasthan Government Health Scheme, Sawai Man Singh Hospital, T-cells